- Home
- ATGL vs ATXS Comparison
ATGL vs ATXS Comparison
Compare ATGL & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATGL
- ATXS
- Stock Information
- Founded
- ATGL 2017
- ATXS 2008
- Country
- ATGL Hong Kong
- ATXS United States
- Employees
- ATGL N/A
- ATXS N/A
- Industry
- ATGL
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- ATGL
- ATXS Health Care
- Exchange
- ATGL Nasdaq
- ATXS Nasdaq
- Market Cap
- ATGL 407.0M
- ATXS 401.2M
- IPO Year
- ATGL 2023
- ATXS 2015
- Fundamental
- Price
- ATGL $21.70
- ATXS $6.56
- Analyst Decision
- ATGL
- ATXS Strong Buy
- Analyst Count
- ATGL 0
- ATXS 7
- Target Price
- ATGL N/A
- ATXS $32.43
- AVG Volume (30 Days)
- ATGL 3.9K
- ATXS 300.0K
- Earning Date
- ATGL 01-01-0001
- ATXS 08-11-2025
- Dividend Yield
- ATGL N/A
- ATXS N/A
- EPS Growth
- ATGL N/A
- ATXS N/A
- EPS
- ATGL N/A
- ATXS N/A
- Revenue
- ATGL $1,590,148.00
- ATXS N/A
- Revenue This Year
- ATGL N/A
- ATXS N/A
- Revenue Next Year
- ATGL N/A
- ATXS N/A
- P/E Ratio
- ATGL N/A
- ATXS N/A
- Revenue Growth
- ATGL 42.17
- ATXS N/A
- 52 Week Low
- ATGL $1.15
- ATXS $3.56
- 52 Week High
- ATGL $57.32
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- ATGL 43.53
- ATXS 59.54
- Support Level
- ATGL $21.51
- ATXS $5.94
- Resistance Level
- ATGL $23.90
- ATXS $6.49
- Average True Range (ATR)
- ATGL 0.85
- ATXS 0.37
- MACD
- ATGL 0.10
- ATXS -0.01
- Stochastic Oscillator
- ATGL 37.32
- ATXS 74.38
About ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.